Beryl Drugs Ltd Q1 FY23 PAT at Rs. 21.83 lakhs

BERYL DRUGS LTD. has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 4.9683 crores during the period ended June 30, 2022 as compared to Rs. 3.5204 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.2183 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -0.4744 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.43 for the period ended June 30, 2022 as compared to Rs. -0.94 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 4.9683 crs	₹3.5204 crs	41.13%
Net Profit	₹0.2183 crs	₹-0.4744 crs	146.02%
EPS	₹0.43	₹-0.94	145.74%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 4.9683 crores during the period ended June 30, 2022 as compared to Rs.4.6483 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.2183 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.3395 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.43 for the period ended June 30, 2022 as compared to Rs.0.67 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 4.9683 crs	₹4.6483 crs	6.88%
Net Profit	₹0.2183 crs	₹0.3395 crs	-35.70%
EPS	₹0.43	₹0.67	-35.82%

Shares of BERYL DRUGS LTD. was last trading in BSE at Rs. 8.84 as compared to the previous close of Rs. 8.84. The total number of shares traded during the day was 48 in over 3 trades.

The stock hit an intraday high of Rs. 8.84 and intraday low of 8.84. The net turnover during the day was Rs. 424.00.

Source : Equity Bulls

Keywords

BerylDrugs Q1FY23 ResultUpdate